Figure 2.
Correlations between changes in BCVA and changes in CST from baseline in patients treated with IAI 2q8 at (A) week 12, (B) week 52, and (C) week 100. Solid lines indicate the correlation line, and dashed lines indicate the 95% CI. Abbreviations: 2q8, 2 mg every 8 weeks after 5 initial monthly doses; BCVA, best-corrected visual acuity; CST, central subfield thickness; IAI, intravitreal aflibercept injection; r, correlation; R2, coefficient of determination.